Aspirin and Reduction of Breast Cancer Risk
Hester Hill Schnipper, LICSW, OSW-C Program Manager, Oncology Social Work
MAY 11, 2017
There have been other studies that suggested that daily aspirin may reduce the risk of breast cancer. Until now, it has not been clear if the risk reduction is related to specific types of breast cancer or whether it is more general. As reported in this article from BreastCancer.Org, a study from City of Hope in California indicates that the association is with ER positive, her2 negative cancers.
To repeat once again: we have long known that daily aspirin is helpful in reducing the risk of cardio-vascular problems. We also know that there are people with other medical conditions that may make a daily aspirin an unwise choice. Speak with your doctor.
For those of us who have already had breast cancer, the leap here is the hope that anything that may reduce the risk of a first diagnosis may also reduce the risk of a recurrence.
Here is the start of the article and a link to read more:
Study Suggests Link Between Low-Dose Aspirin and
Lower Risk for Specific Type of Breast Cancer
Many people take low-dose aspirin (also called baby aspirin) to reduce the
risk of heart disease. A low dose of aspirin is 81 mg per day. Aspirin
reduces inflammation and is also a weak aromatase inhibitor. Aromatase
inhibitor medicines -- Arimidex, Aromasin, and Femara -- are used to treat
hormone-receptor-positive breast cancer.
Earlier studies have suggested that people who regularly take low-dose aspirin may have a lower risk of breast and some other cancers. Still, these studies didn’t look at whether any possible risk reduction was linked to the characteristics of the breast cancer.
A preliminary study suggests that women who take low-dose aspirin 3 or more times per week have a lower risk of hormone-receptor-positive, HER2-negative breast cancer. Still, experts say that it’s too soon to recommend women start taking low-dose aspirin to reduce breast cancer risk.
The study was published online on May 1, 2017 by the journal Breast Cancer Research. Read “Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.”